Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of zenocutuzumab in NRG1 fusion-positive cancer
    Journal Article

    Schram, A. M.; Goto, K.; Kim, D. W.; Macarulla, T.; Hollebecque, A.; O'Reilly, E. M.; Ou, S. H. I.; Rodon, J.; Rha, S. Y.; Nishino, K.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Multimodal treatment in locally advanced esophageal adenocarcinoma - Two interventions better than three?
    Editorial

    Kelsen, D. P.
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types
    Journal Article

    Semaan, K.; Nawfal, R.; Nally, E.; Janjigian, Y. Y.; Robert, C.; Peters, S.; Powles, T.; Choueiri, T. K.
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases
    Journal Article

    Gui, C.; Walch, H. S.; Mueller, K. D.; Boe, L. A.; Ilica, A. T.; Strong, J.; Eichholz, J. E.; Yu, K. K. H.; Wilcox, J. A.; Manca, P.; more...
    Journal of Neurosurgery (2025)

    Fulltext@MSK | Save
  • Locally advanced microsatellite instability-high esophagogastric cancer: Are we ready to change our treatment paradigm?
    Editorial

    Ilson, D. H.
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
    Journal Article

    André, T.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Current management of advanced hepatocellular carcinoma
    Review

    Abou-Alfa, G. K.; Huitzil-Melendez, F. D.; O’Reilly, E. M.; Saltz, L. B.
    Gastrointestinal Cancer Research (2025)

    Fulltext@MSK | Save
  • HERIZON-BTC-302: A phase 3 study of zanidatamab with standard-of-care (SOC) therapy vs SOC alone for first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive advanced/metastatic biliary tract cancer (BTC)
    Meeting Abstract

    Harding, J. J.; Macarulla, T.; Pant, S.; Wu, X.; Garfin, P. M.; Okusaka, T.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in patients with metastatic pancreatic cancer with germline BRCA1 or BRCA2 mutations: SWOG S2001 NCT04548752
    Meeting Abstract

    Chung, V.; Guthrie, K. A.; Pishvaian, M. J.; Lowy, A. M.; Sohal, D.; Reiss, K. A.; Sanford, N. N.; Allegra, C.; Colby, S.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • MOONRAY-01, a phase 1 study of LY3962673, a potent, orally bioavailable, and selective KRAS G12D inhibitor in KRAS G12D -mutant solid tumors
    Meeting Abstract

    Lakhani, N. J.; Melisi, D.; Subbiah, V.; Ammakkanavar, N. R.; O'Reilly, E. M.; Cassier, P. A.; Wainberg, Z. A.; Duffy, A. G.; Patnaik, A.; Fujiwara, Y.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save